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The ability to detect radiation in microfluidic devices is important for the on-chip analysis of radiopharmaceuticals, but 
previously reported systems have largely suffered from various limitations including cost, complexity of fabrication, and 
insufficient sensitivity and/or speed. Here, we present the use of sensitive, low cost, small-sized, commercially available 
silicon photomultipliers (SiPMs) for the detection of radioactivity inside microfluidic channels fabricated from a range of 
conventional microfluidic chip substrates. We demonstrate the effects of chip material and thickness on the detection of 
the positron-emitting isotope, [18F]fluoride, and found that, while the SiPMs are light sensors, they are able to detect 
radiation even through opaque chip materials via direct positron and gamma () ray interaction. Finally, we employed the 
SiPM platform for analysis of the PET (positron emission tomography) radiotracers 2-[18F]fluoro-2-deoxy-D-glucose 
([18F]FDG) and [68Ga]gallium-citrate, and highlight the ability to detect the  ray emitting SPECT (single photon emission 
computed tomography) radiotracer, [99mTc]pertechnetate. 
Introduction 
The field of nuclear medicine includes two very important 
medical imaging techniques for diagnosis and monitoring in 
oncology, cardiology and neurology: positron emission 
tomography (PET) and single photon emission computed 
tomography (SPECT).
1
 Both rely on the injection of a
radioisotope-labelled compound, a so-called radiotracer or 
radiopharmaceutical, into the patient that targets specific 
conditions or diseases and allows their position to be located 
via radiodetectors. PET employs radiotracers labelled with 
positron (
+
)-emitting isotopes (e.g. 
18
F, 
11
C, 
68
Ga, 
64
Cu), which
release positrons that annihilate with electrons to form two 
anti-parallel gamma () rays (511 keV each) that are picked up 
by a ring of radiodetectors.
1-3
 SPECT typically utilises
radioisotopes that directly emit rays (e.g. 
99m
Tc, 
123
I, 
67
Ga)
and picks up the signals using a gamma camera.
1, 4, 5
 PET in particular has recently begun to experience a 
paradigm shift in terms of the production of radiotracers. 
Conventionally, such tracers are generated in large batches in 
a production facility before being transported to the imaging 
centre, and are often restricted to the most widely used PET 
radiotracer: 2-[
18
F]fluoro-2-deoxy-D-glucose ([
18
F]FDG).
6-8
While this is cost effective, it results in a “one-size-fits-all” 
scenario that is not necessarily optimal for the patient. In 
recent years the concepts of “decentralised production” 
9-11
and “dose-on-demand” 
12-15
have gained a great deal of 
interest, whereby a single dose of the most suitable 
radiotracer would be produced on-site for a specific patient or 
group of patients, enabling a more stratified approach to 
patient treatment. 
Key to dose-on-demand is the use of microfluidic devices,
16
which are ideally placed to handle and synthesise the low 
volumes of radioactive solutions available, whilst reducing 
shielding requirements and radiation exposure to personnel. 
Indeed, the synthesis of PET radiotracers, particularly [
18
F]FDG,
in microreactors has been under development for a decade,
10, 
11, 17-23
 but it is only recently that such devices have reached 
sufficient maturity for release onto the market. However, 
while the radiosynthesis step has been successfully 
miniaturised, other aspects of radiotracer production have 
largely been ignored, including the quality control (QC) testing 
steps that are essential in ensuring the safety and purity of the 
radiotracer dose. For example, [
18
F]FDG requires a number of
QC tests,
24, 25
 many of which require some form of radiation
detection for determination of: activity (in units of becquerel, 
Bq, or curie, Ci), half-life (t½, for identification/confirmation of 
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the radionuclide, e.g. 
18
F), and radiochemical purity/identity
via thin layer chromatography with a radiodetector (radio-TLC) 
and high performance liquid chromatography with a 
radiodetector (radio-HPLC). 
 We are developing an integrated microfluidic platform for 
the quality control testing of PET radiopharmaceuticals,
26, 27
and a crucial aspect of such a platform is the incorporation of 
suitable miniaturised radiodetectors. Only a handful of such 
detectors have thus far been demonstrated with microfluidic 
systems, often via the detection of Cherenkov light,
28
 emitted
when a charged particle travels through a medium (with 
refractive index, n) at a velocity (v) faster than the phase 
velocity of light through that medium (i.e. v > c/n), or 
scintillation light;
29
 photons generated by electrons that have
been excited by ionising radiation falling back to lower atomic 
levels. Examples of on-chip radiodetection include performing 
conventional autoradiography via phosphor imaging of chips
30-
32
imaging via plastic scintillators
33
 and inorganic scintillators,
34, 
35
Cherenkov imaging via a CCD camera,
36-38
 a PIN silicon
photodiode array,
39-41
 a solid-state beta-particle camera
consisting of a position-sensitive avalanche photodiode 
(PSAPD),
42-45
 and the use of liquid scintillators within
microfluidic channels.
46, 47
 However, these methods can suffer
from limitations including expense, size, speed, sensitivity, and 
complexity of fabrication. 
 Here, we investigate the potential of silicon 
photomultiplier (SiPM) technology for radiation detection, 
with a view to future incorporation into an integrated QC 
platform. SiPMs are solid-state silicon-based photodiode light 
detectors
48, 49
 that are sensitive to single photons, with a dark
count rate of <100 kHz mm
-2
, and have recently improved
greatly in terms of price and sensor size, as well as in 
performance which is approaching that of conventional PMTs. 
SiPMs have become especially suited to scaled-down systems, 
making them ideal for integration with microfluidic systems. 
Here, we evaluate the performance of an array of SiPMs for 
the detection of radiation from the positron-emitting isotope, 
[
18
F]fluoride, in a microfluidic channel, with an initial view to
determination of the activity and half-life of synthesised 
radiotracers. We further study the effect of commonly used 
microfluidic substrates and substrate thickness on the 
detection signal, and study the origins of the detection signal. 
Finally, we apply the SiPM platform to the on-chip analysis of 
the clinically relevant PET radiotracers, [
18
F]FDG and
[
68
Ga]gallium-citrate, and the SPECT radiotracer,
[
99m
Tc]pertechnetate.
Experimental 
Chemicals and reagents 
All solutions and dilutions were prepared in high purity water 
(18.2 M cm at 25 °C) that had been double-filtered (0.05 m) 
through an ELGA Option 4 system that fed into an ELGA UHG 
PS system (ELGA Process Water, Marlow, UK). Hydrochloric 
acid (37 %) for elution of [
68
Ga]gallium from a generator was
purchased from Fisher Scientific (Loughborough, UK). A 
solution of 0.1 M citric acid was prepared for [
68
Ga]gallium
labelling by dissolving 0.42 g of the citric acid (Fisher Scientific) 
in 20 mL of water. 
All chemicals for [
18
F]fluoride production and [
18
F]FDG
synthesis were purchased from ABT Molecular Imaging 
(Knoxville, TN, USA) and used without further purification. 
Original suppliers of these chemicals were Rotem Industries 
Ltd. (Israel) for the 
18
O-enriched (>95 %) target water, and ABX
GmbH (Radeberg, Germany) who supplied the vials of 
mannose triflate, phase transfer catalyst (containing cryptand 
2.2.2 and potassium carbonate in acetonitrile with a small 
amount of water), acetonitrile, water for injection, and 
hydrochloric acid (2 M). 
Preparation of radioisotopes and radiotracers 
[
18
F]fluoride radioisotope
[
18
F]fluoride radioisotope was prepared by proton
bombardment of 280 L of 
18
O-enriched target water, via the
18
O(p,n)
18
F nuclear reaction, using the BG75 Biomarker
Generator cyclotron (ABT Molecular Imaging).
15, 50
 Irradiation
of the target water was performed with a 7.5 MeV proton 
beam (4.2 A). The [
18
F]fluoride was then transferred
automatically to a 1.5 mL Eppendorf tube for further 
Fig. 1 Setup of the microfluidic chip and silicon photomultiplier (SiPM array). (a) Exploded schematic of the microfluidic chip, 
consisting of a milled serpentine channel in a substrate that was bonded to a top plate. The milled plate material and thickness 
was varied throughout this work. The completed chip was situated in a chip holder over a silicon photomultiplier (SiPM) array. 
(b) Photograph of the final chip setup on the SiPM array. (c) Schematic depicting the relative position of the microfluidic channel 
to the SiPM cells. Cells 6, 11, and 14 (highlighted in red) were used for counting of activity in the microchannel. 
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processing. Dilutions were prepared as necessary with purified 
water in order to achieve the desired activity per volume (i.e. 
MBq mL
-1
).
[
18
F]FDG radiotracer
[
18
F]FDG radiotracer was prepared by first generating the
[
18
F]fluoride ion as described above. However, following
proton bombardment the radioisotope was instead 
transferred to the BG75 Biomarker Generator’s Card Chemistry 
System (CCS),
15, 50
 which had been pre-prepared with reagent
vials. [
18
F]FDG synthesis was performed using a dose synthesis
card (DSC), which allows production on a dose-on-demand 
basis via nucleophilic substitution of mannose triflate with 
[
18
F]fluoride.
6
 A sample of [
18
F]FDG was automatically injected
into the BG75’s automated quality control platform to test for 
chemical and radiochemical purity,
15, 50, 51
 while the remainder
of the dose (~2.3 mL) was dispensed into a syringe for 
collection. 
[
68
Ga]gallium-citrate radiotracer
[
68
Ga]gallium was eluted from a 740 MBq 
68
Ga/
68
Ge generator
(iThemba LABS/IDB Holland) in 0.6 M HCl and processed for 
synthesis as described in the literature.
52
 Briefly, the eluate
was purified via retention on a Strata-X-C strong cation 
exchange column (Phenomenex, Macclesfield, UK), before 
being eluted in a mixture (98:2) of acetone and 0.1 M 
hydrochloric acid. The purified [
68
Ga]gallium was then dried
under vacuum at 90 °C in a heating block. Once cooled to room 
temperature, a 0.1 M solution of citric acid was added to the 
dried [
68
Ga]gallium and allowed to react for 15 min with
agitation to form a solution of [
68
Ga]gallium-citrate
radiotracer. 
[
99m
Tc]pertechnetate radiotracer
A solution of the gamma-emitting radioisotope, 
[
99m
Tc]technetium, was eluted from an 2.15 GBq Ultra-
Technekow DTE 
99
Mo/
99m
Tc generator (Mallinkrodt 
Pharmaceuticals, Ireland) in saline solution as sodium 
[
99m
Tc]pertechnetate (Na
99m
TcO4). This was used without
further processing other than dilution in purified water to the 
desired activity. 
SiPM detector design 
The detection setup consisted of a SensL C-Series MicroFC-
SMA-30035 4x4 SiPM array (SensL, Cork, Ireland) (Fig. 1). The 
30035 model contains 4774 microcells per 3 x 3 mm
2
 cell,
allowing for a significant dynamic range, and the 4 x 4 SiPM 
array thus consisted of sixteen of these cells packed such that 
there was only 200 m of inactive space between adjacent 
cells. The system read-out was via SensL’s own 
evaluation/preamplifier board sections (model numbers: 
ArraySB4-EVB-PixOut, ArraySB4-EVB-PreAmp) with an adaptor 
break-out board courtesy of LabLogic Systems Ltd. (Sheffield, 
UK) for use with the C-Series SiPM array. This allowed full 
access to the individual and summed outputs of the device. 
The preamplifier board provided the 5 V power supply 
required, while the bias voltage of 28 V was supplied via an 
external power supply unit (Aim and Thurlby Thandar 
Instruments, Cambridgeshire, UK). Fig. S1 in the ESI shows the 
disassembled components of the SiPM platform, and the 
complete setup. 
Microfluidic chip design and fabrication 
The microfluidic chip design consisted of a serpentine channel 
that was directly milled into square (30 mm x 30 mm) glass and 
plastic substrates via CNC micromachining
53
 using a Datron M7
milling machine (Datron, Germany). The channel, which was 
designed to be filled with a known volume of solution while 
covering the entire area of the SiPM array (in particular the 
SiPM cells of interest), had a width of 1.0 mm, a depth of 450 
m, and a length of 94.2 mm, thereby holding an approximate 
volume of 40 ± 2 L given tolerances of the manufacturing 
process (Fig. 1). Due to the fabrication technique, the channels 
featured an approximately square-section profile. All chips 
were sealed using a square (30 mm x 30 mm) top plate 
fabricated from 1.5 mm thick poly(methyl methacrylate) 
(PMMA) that was bonded with transparent double-sided tape 
(RS Components, Corby, UK) to the milled substrate. The top 
plate had an inlet hole and an outlet hole drilled into it (2 mm 
diameter each), while corresponding holes were punched into 
the double-sided tape prior to bonding. 
 Two main studies were performed using the devices to 
determine the effect of (1) the type of substrate material, and 
(2) the thickness of the substrate material. In the first scenario, 
the serpentine channel was fabricated in 4 mm thick 
substrates of poly(methyl methacrylate) (PMMA), 
polycarbonate (PC), B-270 crown glass, soda-lime glass, and 
Borofloat glass. The effect of substrate thickness was studied 
by milling the serpentine channel into polycarbonate 
substrates of 2 mm, 4 mm, 6 mm, 8 mm, 10 mm and 12 mm 
thickness. 
 The ability to detect radioactivity through opaque 
materials using the light-sensing SiPM array was tested by 
milling the channel into 4 mm and 8 mm thick PC substrates 
that were subsequently coated with aerosol gloss black spray 
paint (RS Components, Northants, UK), referred to as “PC 
opaque”. Further tests were also performed using opaque 
chips fabricated from polytetrafluoroethylene (PTFE), with 
thicknesses of 2 mm and 12 mm. 
 Chip holders were produced to achieve consistent results 
by ensuring the location of the microfluidic channel with 
respect to the SiPM array, as depicted in Fig. 1. The holders 
were 3D-printed from opaque PLA (polylactic acid) using a 
Makerbot Replicator 2X 3D printer. Their dimensions were 35 
mm long x 35 mm wide x 6 mm deep, and featured a 31 mm x 
31 mm shelf on which to house the chip. An 18 mm x 18 mm 
window allowed the serpentine channel to be placed directly 
over the SiPM array. Thus, fixing the relative positions of the 
SiPM cells to the microfluidic channel ensured that the 
measured count rate was not artificially increased or 
decreased by varying the distance between the source and the 
detector. 
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Experimental procedure 
Briefly, experiments were performed by filling the microfluidic 
channel with radioactivity, determining the amount of activity 
in the channel via a dose calibrator, and then placing the chip 
on the SiPM array for detection. 
 First, the required radioisotope/radiotracer was prepared 
and diluted with purified water such that 40 L of solution 
would contain a desired level of radioactivity (in MBq) and 
thus concentration of radioactivity (i.e. MBq mL
-1
) appropriate
for each experiment. This 40 L volume was introduced into 
one of the chip access holes via a pipette, after which a layer 
of tape was placed over the access holes to ensure that no 
evaporation could occur and to prevent contamination by 
spillage. The chip was then placed into the 3D printed chip 
holder, before measurement in a CRC-55t PET dose calibrator 
to determine the amount of activity at a reference time point, 
where after the level of activity remaining in the chip at certain 
time points could be determined using the half-life equation 
for the appropriate radiotracer. 
 With the known activity recorded, the chip (with holder) 
was then placed onto the SiPM array for data collection. The 
SiPM array was housed in a box with a fold-down lid to ensure 
that no external light could reach the detector. Data was 
recorded by monitoring detection signals from four of the 
SiPM outputs (Fig. 1c): two near the centre of the chip 
(outputs from cells 6 and 11), one near the inlet port (output 
from cell 14), and finally the summed output of all of the cells. 
Counting data from the radioactive sources was collected for 5 
min by connecting the selected outputs to a CAEN N841 
discriminator and CAEN N1145 quad scaler system. The 
discriminator threshold was set to 85 mV and 30 mV for the 
sum and individual outputs, respectively. These thresholds 
were selected by viewing pulses on a LeCroy Waverunner 6100 
oscilloscope and triggering on the positive edge. ROOT 
software,
54
 an open-source analysis framework, was used for
analysis and plotting of collected counting data from output 
channel 11. Error bars are present for each data point in the 
plots throughout this paper, but it should be noted that in 
some cases the error bars are smaller than the size of the 
marker point. 
Geant4 penetrability simulations 
An initial study of SiPM performance had taken place prior to 
the work reported here, utilising a similar SiPM detector setup 
as described here but using a standard 
22
Na disk source (Fig. S2
in the ESI) as a positron emitter (546 keV positron energy) to 
provide the subsequent 511 keV annihilation  rays. To test the 
viability of detecting Cherenkov light using the SiPMs, which 
would directly examine the positron as opposed to the 
resultant  rays, a series of Geant4 penetrability simulations 
were performed.
55
 These investigated the maximum
penetration depth of positron tracks from various potential 
positron emitters for several common microfluidic substrates. 
The results of these simulations are shown in Fig. 2, and 
confirm that while a 
22
Na source is a suitable proxy as a source
of annihilation photons ( rays), the 546 keV positron itself 
would almost certainly be stopped within the plastic surround 
(~4 mm thick) of the 
22
Na disk. This information allowed the
prospective substrate thicknesses to be limited for subsequent 
studies. 
Results and discussion 
Effect of material type 
Microfluidic chips were constructed from a variety of substrate 
materials consisting of a selection of plastics and glasses 
commonly used in microfluidics. The purpose here was to 
establish whether the SiPM response was a function of 
material choice. The glass chips tested were fabricated from 
B270 crown glass, Borofloat glass, and soda-lime glass, while 
the plastics consisted of polycarbonate (PC) and polymethyl 
methacrylate (PMMA). All of the milled substrates featuring 
the serpentine channel were 4 mm thick with a 1.5 mm thick 
PMMA top plate. Some of the physical properties of the 
Fig. 2 Maximum depth of penetration for positrons in a variety of commonly used microfluidic substrate materials. The 
endpoint energies of positron-emitting isotopes of choice have been marked on the graph for reference. 
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materials are listed in Table S1 in the ESI. These properties 
directly affect positron penetrability, with the maximum depth 
of positron penetration expected to be lower for more dense 
materials. 
A solution of [
18
F]fluoride (40 L) was added to each chip,
the radioactivity level (in MBq) was then measured in a dose 
calibrator and the reference time recorded, before being 
placed on the SiPM array. The count rate observed by the SiPM 
was recorded over 5 minutes, and the resultant plot of SiPM 
count rate (counts per second, cps) versus radioactivity (MBq) 
is shown in Fig. 3a. High levels of radioactivity (e.g. 8 MBq) 
could yield ~10
5
 counts over the 5 min time frame, giving
count rates of around 300 cps. Comparatively, when the chips 
were placed on the SiPM array without any radioactivity as 
negative control tests, only 0 – 7 counts were recorded over 5 
min, giving maximum count rates of 0.02 cps. 
 Results largely showed reasonable linearity for each 
material other than PMMA, and similar count rates were 
recorded. Unfortunately, a problem with the CNC milling of the 
PMMA chip caused its channel to be deeper than intended. 
This meant that the dose did not evenly distribute throughout 
the channel and some internal movement throughout the 
experiment is suspected. As a result, the plot points for PMMA 
show a great deal of variation around the best fit line, and 
while they show the general trend of decreasing count rate 
with decreasing activity, the results cannot be taken as 
absolute values for that material.  
 Discounting the PMMA material due to the 
aforementioned issues, the glass chips all exhibited lower 
count rates compared to the polymer PC chip, likely due to the 
higher density of the glasses (see Table S1 in the ESI) that 
would attenuate positrons/gamma rays to a greater extent 
than less dense plastics. However, given the densities of the 
materials, it may have been expected that Borofloat glass ( = 
2.20 g cm
-3
) would give the best results of the three glasses,
followed by soda-lime ( = 2.52 g cm
-3
) and then B270 ( =
2.55 g cm
-3
), while in fact the opposite was observed, although
the densities between the materials were largely quite similar. 
This may mean that at the 4 mm material thickness, the 
density of the material may not cause a huge effect on the 
detected signal and may be the result of other aspects such as 
material composition. Low-level fluorescence caused by 
exposure to radiation (i.e. scintillation) could be another 
potential source of signal in some of the materials, although 
none of the materials used here are known to have significant 
scintillating properties. Furthermore, due to the lack of a 
dopant present in the material, any such scintillation light 
would not necessarily be at a wavelength within the detector’s 
spectral response range. These aspects will require further 
investigation in the future. Still, in all, these initial results 
demonstrated the suitability of the SiPM array for the 
detection of radiation from positron-emitting radioisotopes in 
a range of conventional microfluidic chip materials and with 
good linearity over a clinically relevant range. 
Effect of material thickness 
Having tested a range of chip materials, the next step was to 
determine the effect of the substrate thickness on the 
acquired signals by varying the distance between the SiPM 
array and radioisotope source in the microchannel. 
Polycarbonate was selected as the substrate for this 
investigation due to the ease with which to prepare the 
different thickness, ranging from 2 mm to 12 mm (with 2 mm 
intervals). As before, [
18
F]fluoride was added to the chips and
the count rates determined on the SiPM array for each chip, as 
shown in Fig. 3b. 
 All results showed good linearity of signal count rate with 
activity, with all data points lying within the error of the fit, 
and demonstrated that as the substrate thickness increased, 
the SiPM signal decreased. For the thinnest substrate tested (2 
mm), the distance between the bottom of the microfluidic 
channel and the chip-SiPM interface was less than the 
Fig. 3 Activity of the [
18
F]fluoride ion in the microfluidic
channel plotted against the SiPM signal count rate in (a) 
various substrate materials (4 mm thick), and (b) 
polycarbonate substrates of varying thickness. Only 
statistical uncertainties are displayed. 
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maximum penetrability of the 
18
F positron (see Fig. 2), and so
in this instance the positron could impinge on the SiPM 
surface. This can be observed in Fig. 3b where the 2 mm thick 
PC count rate is significantly higher than the spread of the 4-12 
mm thick substrates, which indicates that the SiPMs are 
susceptible to direct positron interaction. By replotting Fig. 3b, 
the dependence of the SiPM signal intensity on the chip 
thickness can be further demonstrated for different activity 
levels (calculated based on the line equations obtained from 
Fig. 3b), and this is shown in Fig. S3 in the ESI. While it would 
be expected that thicker substrates would allow the 
generation of more Cherenkov light due to positrons being 
allowed to travel to their greatest extent and generate more 
light, the fact that the SiPM signal decreased with increasing 
thickness suggests that the Cherenkov component of the signal 
may in fact be minimal. Instead, a major source of the SiPM 
signal appears to be due to direct interaction with positrons, 
which clearly lessens as the substrate thickness increases. 
Some of the signal may also have been due to direct  ray 
interaction with the SiPM array. Interestingly, Cho et al.
36
demonstrated previously that conventional photomultiplier 
tubes (PMTs) were also susceptible to direct interaction with 
the 511 keV  rays resulting from positron-electron 
annihilation at high activity levels, yielding a signal even in the 
absence of light. Future work on this could involve a more 
focussed study on the contribution of each signal source 
(positron interaction,  ray interaction, Cherenkov light, and 
possible scintillation) at different distances from the detector 
in order to better understand the relevant mechanisms and 
dependences, and to validate the theories and interpretation 
we have proposed here. 
Material opacity study 
In order to isolate the source of the pulses detected by the 
SiPM, a study was performed to remove the Cherenkov and 
potential scintillation components of the signal by comparing 
opaque substrate materials to transparent ones. Transparent 
PC chips were used just as before, while to prepare opaque 
chips the underside of 4 mm and 8 mm thick PC substrates 
were painted black, with an additional sheet of black plastic 
placed between the chip and the SiPM array (Fig. S3 in the ESI). 
The black plastic had been shown to completely attenuate the 
light from a blue LED placed in close proximity to the SiPM. 
The results for both the opaque and transparent 4 mm and 8 
mm thick PC substrates are shown in Fig. 4, and demonstrate 
very similar effects between the opaque and transparent 
variations. The use of 4 mm, and particularly 8 mm, thick 
substrates meant that the SiPM array would have been 
shielded from direct positron interaction, while the use of 
paint and a plastic sheet shielded the SiPMs from Cherenkov 
emission and the possibility of scintillation light. Hence, the 
fact that signal could still be detected can only be explained if 
the SensL C-Series device is sensitive to low-energy  rays 
created through the annihilation of the positron and any 
subsequent Compton scattering. The results showed that the 
transparent PC materials yielded slightly higher count rates 
than their opaque counterparts, likely due to the presence of 
Cherenkov light generated as positrons passed through the 
material, with low-level scintillation also a possibility. 
However, the relatively small differences between the opaque 
and transparent chip results suggested that the main 
components of the signal were due to direct positron and/or  
interaction with the SiPM. 
Further tests were performed in which [
18
F]fluoride was
introduced into 2 mm and 12 mm thick substrates of opaque 
PTFE polymer. Signals were again detected even with the 
opaque materials, reiterating the conclusions of the previous 
opacity test (Fig. S4 in the ESI), while also demonstrating once 
more that the thinner substrate yielded much higher signals 
than the thicker substrate. 
Linearity of [
18
F]fluoride signal
Typical activities injected into a patient for a PET scan will be in 
the order of 370 MBq (10 mCi), while the actual volume of 
solution can vary (e.g. around 0.5-15 mL). The ABT Biomarker 
Generator produces [
18
F]FDG in a dose-on-demand format,
delivering a final syringe of 2.3 mL volume. Thus, if we assume 
a minimum activity of 370 MBq in that injection volume, as an 
example, then the “concentration” of activity would be 160 
MBq mL
-1
, or 0.16 MBq L
-1
. Thus, a minimum clinically
relevant level of radioactivity from the ABT platform for 
detection with our system would be 6.4 MBq in the 40 L 
channel volume. On the other hand, if 10 mL is taken as a 
typical or average injection volume, then the concentration 
would be 0.037 MBq L
-1
 (37 MBq mL
-1
) and so the activity in
40 L would be 1.5 MBq. Furthermore, since 370 MBq would 
be used for an actual injection, any analysis taking place prior 
to injection would contain greater levels of activity than this. 
 In order to confirm that we were able to measure such 
clinically relevant activities, a new set of measurements was 
performed to test the linearity of the detection signal across 
this region of interest. [
18
F]fluoride was introduced into 4 mm
thick substrates of B-270 glass, PMMA, polycarbonate, and 
opaque polycarbonate (painted black and with a plastic sheet Fig. 4 Comparison of SiPM signal for transparent and 
opaque polycarbonate (PC) substrates. Signal was obtained 
even from the opaque materials. 
 ARTICLE 
J. Name., 2013, 00, 1-3 | 7  
Please do not adjust margins 
Please do not adjust margins 
placed between it and the SiPM array, as described earlier). 
The major difference between this study and the earlier 
material investigation was the range of activities that were 
tested, with activities measured between ~100 MBq and ~0.01 
MBq in the microfluidic chip at several time points. The results 
of this extended linearity study are shown in Fig. 5a. 
Uncertainties in the data points comprised the √n statistical 
component as well as a 10 % systematic error. This allowed 
coverage across four orders of magnitude in activity, and 
confirmed the linearity of our system across the clinically 
relevant region, highlighting the suitability of the technique for 
the analysis of PET radiotracers. With this, it should be 
feasible, upon preparation of a calibration curve of SiPM signal 
versus activity for a given microfluidic chip (standardised 
material, thickness and channel design etc.) and a given 
radioisotope-labelled pharmaceutical, to determine the level 
of radioactivity in an unknown sample, akin to a dose 
calibrator, as part of an integrated platform in which the 
operator would not be required to directly handle any 
radioactivity. These results also demonstrate that while the 
current volume of solution in the microchannels (40 L) is 
actually quite large from a microfluidics point-of-view, it could 
significantly reduced whilst still allowing detection in the 
relevant MBq range. 
Half-life measurement of [
18
F]fluoride
The determination, and confirmation, of the isotopic half-life 
(t½) is a key QC criterion that must be met by any system 
intended to satisfy the “radionuclidic identity” test, to ensure 
that the radiation is due to the expected radioisotope source. 
[
18
F]fluoride has a documented t½ of 109.7 min.
56
 According to
the British Pharmacopoeia 2012, the approximate half-life of a 
[
18
F]fluoride-labelled molecule should be determined “by no
fewer than 3 measurements of the activity of a sample in the 
same geometrical conditions within a suitable period of time 
(for example, 30 min)”, and results should yield a half-life 
between 105 to 115 min.
57
 Some authors have suggested that
a suitable time period is 20-30 min,
25
 while others have
suggested that as little as 10 min is suitable.
24, 58
 Although no
instrument is specified for the analysis, a dose calibrator is 
often employed. 
 In order to determine whether half-life could be calculated 
using the SiPM system, [
18
F]fluoride was added to a
polycarbonate chip (4 mm thick), the activity measured in a 
dose calibrator, and counting data taken for 5 min. The activity 
was allowed to decay over 6 hours, i.e. approximately three 
half-lives, and counting data taken at several points during this 
acquisition window. The results are shown in Fig. 5b, and from 
these the half-life was calculated to be 109 ± 6 min for 
[
18
F]fluoride. This demonstrates the ability to obtain a fairly
accurate value for the half-life of a radioisotope using the SiPM 
platform, although there are clearly some issues with precision 
(± 6 min) that would need to be addressed before use in a 
clinical setting could be achieved. Sources of noise and errors 
within the platform will need to be characterised in future 
tests. For example, such sources could include noise produced 
by the 20-to-40 pin adaptor situated between the SiPM array 
and the preamplifier board; a component that could be 
removed in a future iteration of the platform. Additional 
improvements to the precision could come from an optimised 
chip with a dedicated design, and further integration of the 
SiPM array (or a single SiPM) with the chip. Furthermore, while 
the 6 hour time frame is clearly unsuitable for a miniaturised 
QC package, it nonetheless indicates that the system is capable 
of making accurate half-life measurements, albeit with a need 
for further optimisation. 
 In addition to the 5 min counts that were taken during the 
previous analysis of half-life, a series of shorter time base 
measurements were also taken in order to ascertain a lower 
limit for half-life determination. Here, 30 s count durations 
were used instead of 5 min, and three measurements were 
spread evenly across a 20 min acquisition window (results not 
shown). However, with such short count times and acquisition 
window, a reliable calculation of the radionuclide half-life 
could not be obtained. More investigation will be required to 
Fig. 5 (a) Study of the linearity of the SiPM signal over four 
orders of magnitude of [
18
F]fluoride activity in 4 mm thick
substrates. The uncertainties comprise the √n statistical 
component as well as a 10 % systematic error. (b) 
Determination of [
18
F]fluoride half-life based on multiple
measurements taken over several half-lives. 
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determine a suitable compromise between count times, 
acquisition window, and accuracy of half-life. 
Analysis of [
18
F]FDG radiotracer
Having established the linearity of the SiPM signal to activity 
and the ability to determine half-life, the platform was tested 
using a sample of [
18
F]FDG, a [
18
F]fluoride-labelled glucose
analogue that is used in oncology, cardiology and neurology.
7
A single dose of [
18
F]FDG (487 MBq in 2.3 mL) was produced
using the ABT Biomarker Generator, and 40 L was added to a 
polycarbonate chip (4 mm thick). The activity in the chip was 
measured in a dose calibrator and then placed on the SiPM 
array. 
 The SiPM signal was measured for 5 min at several time 
points as the [
18
F]FDG sample decayed, and the resultant
count rates were compared to the [
18
F]fluoride taken from the
linearity study for 4 mm thick polycarbonate (see Fig. 5a). The 
results are shown in Fig. 6a, and clearly demonstrate how 
closely the [
18
F]FDG count rates match the [
18
F]fluoride, as
would be expected since the radionuclide is the same. Most 
significantly, the results demonstrate that the SiPM platform, 
with appropriate calibration, can be used to determine the 
amount of radioactivity (and thus concentration in MBq mL
-1
)
of an unknown sample of a PET radiotracer that contains the 
same radionuclide. 
Furthermore, as with the [
18
F]fluoride measurements, an
exponential could be fitted to the [
18
F]FDG data to establish
the half-life of the sample. A double dataset was taken in this 
instance. The first was a long time base measurement with the 
standard 5 min counts taken three times over the course of 
160 min (black data points in Fig. 6b). Between these 5 min 
counts a second dataset was taken in parallel to investigate 
the limitations of both sample rate and time base. Here, three 
batches of counts were recorded over 160 min, with each 
batch consisting of ten 60 s counts taken at approximately 60 s 
intervals (i.e. ~20 min total per batch). The data points are 
illustrated in Fig. 6b, with batch 1 (data points 1-10) shown in 
light green, batch 2 (data points 11-20) in turquoise, and batch 
3 (data points 21-30) in blue. 
 These data were then analysed in two ways. In the first 
method, both the 5 min count and the 60 s count data points 
had an exponential curve fitted to extract the half-life in the 
same manner as for the [
18
F]fluoride measurements. The 60 s
counts were combined into a single dataset and then 
successively down-sampled, with further fits performed. The 
result was that down-sampling had a negligible effect on the 
calculated half-life, even when greatly reducing the number of 
data points from 30 (three batches of ten readings each) down 
to 5. However, a reduction in the time base to consider a 
single 20 min batch produced wildly inaccurate results. 
 The second data analysis technique was to constrain the fit 
of the 60 s data points by calibrating with the long time base 
data and then fitting over a dataset with a time base more 
acceptable to a final product (approximately 20 min). The fit 
parameters from the long time base (5 min counts) data were 
extracted and used to constrain the slope parameter of the 
exponential fit to the short time base (60 s counts) batches, 
with the limits of the constraint set to ±1, while allowing the 
constant parameter to be freely varied. Both sets of data are 
shown in Fig. 6b, with the constrained exponential fits used to 
determine the half-life. This technique was applied to data 
with a time base of 20 min and counting times of 60 s and 
produced a far more accurate result than allowing full degrees 
of freedom. The half-life calculated by this method was found 
to be 110.3 ± 7.4 min by limiting the constraint of the 
exponential fit by 1, offering reasonable accuracy for 
determining the half-life of a [
18
F]fluoride-labelled radiotracer
in a microfluidic channel with a suitable QC time frame of 20 
min. However, as discussed in the previous section, further 
characterisation, optimisation, and the use of a dedicated 
setup will be needed to achieve the precision required for 
clinical use, and this will form an essential part of future 
experiments. 
Fig. 6 (a) The fit of SiPM signals for [
18
F]FDG (red) to the
linearity plot of [
18
F]fluoride (orange) taken from Fig. 5a,
demonstrating the potential for the determination of 
activity levels of radiotracer samples. The substrate was 4 
mm thick polycarbonate (PC4). (b) Measurement of 
[
18
F]fluoride half-life from a sample of [
18
F]FDG. The dataset
was reanalysed with different parameters to determine the 
likely limitations of the system. 
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 These analytical methods thus demonstrate the suitability 
of the SiPM setup for satisfying the demands of the 
Pharmacopoeia in terms of the required accuracy and time 
frame.  
Analysis of [
68
Ga]gallium-citrate radiotracer
Having performed investigations of the SiPM platform using 
the [
18
F]fluoride the [
18
F]fluoride-labelled radiotracer,
[
18
F]FDG, we also wished to determine the technique’s
suitability to measuring other radioisotopes/radiotracers used 
in PET medical imaging. [
68
Ga]gallium is garnering a great deal
of interest for use in PET imaging, thanks to its short half-life 
(t½ = 68 min) and decay characteristics,
59-61
 and the ability to
produce the radionuclide using a compact 
68
Ge/
68
Ga
generator. In recent years, the labelling of PET tracers with 
[
68
Ga]gallium for PET imaging has been achieved in microfluidic
devices,
23, 62-65
 and so the ability to analyse these radiotracers
in a miniaturised platform is highly relevant. Here, we 
prepared a solution of [
68
Ga]gallium-citrate, a PET radiotracer
used for the imaging of infection, inflammation and 
tumours,
66-69
 as a test model for the SiPM platform.
A solution of the [
68
Ga]gallium-citrate (40 L) was
introduced into transparent polycarbonate (4 mm, 6 mm, and 
8 mm thick), PMMA (4 mm) and B270 glass (6 mm) chips. The 
results, shown in Fig. 7, demonstrated that the positron-
emitting [
68
Ga]gallium radioisotope could be detected using
the SiPM array. Similar trends to the [
18
F]fluoride results were
obtained, with the detection signal increasing linearly with 
radioactivity, and activity values up to around 8 MBq yielding 
similar count rates between the two radioisotopes. As before, 
reducing the thickness of the PC substrate yielded a much 
greater increase in signal, while signal was also observed in the 
PMMA and B270 glass substrates. The PMMA showed results 
that are considered to be unreliable in terms of absolute 
values due to the problems with the fabrication mentioned 
previously, but nonetheless showed a linear response in terms 
of the trend. Tests were also performed using opaque PTFE 
and (painted) PC substrates, with detection signals once more 
highlighting the fact that while Cherenkov light may contribute 
to the detection signal, the main modes of detection occurring 
appear to be direct interaction between positrons and/or  
rays with the SiPM array. 
 The results highlighted that the SiPM detection system was 
suitable for a variety of radioisotopes and radiotracers, which 
could include [
11
C]carbon-based radiopharmaceuticals that are
of interest due to their short half-life (t½ = 20.4 min)
56
 and like-
for-like atom replacement in well characterised organic drug 
molecules to give a negligible radionuclide effect compared to 
the addition of [
18
F]fluoride.
1
Analysis of [
99m
Tc]pertechnetate radiotracer
While the detection of positron-emitting radioisotopes had 
been demonstrated, the results had suggested that the SiPM 
array may have been measuring rays directly as one of the 
sources of signal. In order to study this further, we 
investigated the measurement of the 140 keV gamma-emitter, 
[
99m
Tc]technetium (t½ = 6 hours). [
99m
Tc]technetium is one of
the most common clinical radioisotopes used in SPECT imaging 
radiotracers.
1, 70-72
 Thus, in addition to exploring whether the
SiPM platform was indeed sensitive to  rays, a positive result 
would also show potential for the measurement of SPECT 
radiotracers as well as PET radiotracers. 
[
99m
Tc]technetium was eluted from a generator as sodium
[
99m
Tc]pertechnetate (Na
99m
TcO4). This molecule provides a
starting material for the radiolabelling of other SPECT 
radiotracers, but is also used as a radiopharmaceutical itself 
for imaging of the brain (blood perfusion) and the thyroid 
(morphology, vascularity, and function).
73
 The
[
99m
Tc]pertechnetate solution was diluted in purified water to
the required level of activity and pipetted (40 L) into a 4 mm 
thick B270 glass chip for counting over 5 min. The chip 
contained 5.3 MBq of [
99m
Tc]pertechnetate, which yielded
signals of 1.7 – 4.2 cps (502 - 1252 counts over 5 min) 
depending on the SiPM output channel, easily demonstrating 
positive detection of the gamma-emitting species above the 
background levels (0 - 7 counts over 5 min, max. 0.02 cps). 
 It is worth noting, however, that the count numbers were 
around 10
3
 times lower than similar activities of [
18
F]fluoride
and [
68
Ga]gallium in the 4 mm thick B270 glass substrates. This
is probably due to the difference in mass attenuation 
coefficients for 140 and 511 keV photons (tabulated at 1.389 x 
10
-1
 cm
2
 g
-1
 and 8.696 x 10
-2
 cm
2
 g
-1
 respectively, in borosilicate
glass),
74
 whereby the lower energy photons are attenuated to
a greater extent and are less likely to hit the SiPM. 
Nonetheless, the detection of [
99m
Tc]technetium proved that,
even in the absence of positrons and Cherenkov light (which is 
generated as positrons pass through a material), the SiPM 
array was sensitive to direct interaction with  rays, albeit to a 
much lower extent compared to the effects of positron 
emission shown in our earlier studies. Scintillation in the glass 
may also be a possibility, although B270 glass is certainly not 
renowned for being a scintillator and so any light generated 
Fig. 7 Activity of the PET radiotracer, [
68
Ga]gallium-citrate,
versus the SiPM count rate for a variety of microfluidic chip 
substrates and thicknesses. The inset results highlight 
measurements taken using opaque chips. 
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would be at a very low level. This could be tested in future by 
repeating the material opacity studies with [
99m
Tc]technetium.
The ability to detect signals from a [
99m
Tc]technetium-
labelled radiotracer means that the detection setup discussed 
here, in addition to being suitable for PET radiotracers, also 
demonstrates potential for the determination of the activity 
and half-life of gamma-emitting SPECT radiotracers. This 
greatly broadens the scope of the integrated quality control 
microfluidic device we are developing to include SPECT as well 
as PET radiotracers. However, the ability to directly detect  
rays also highlights new chip design considerations for such a 
QC platform, since an SiPM detector placed on the chip would 
detect rays from any other on-chip location containing 
gamma-emitters (for SPECT) or positron-emitters (for PET), 
such as inlet/outlet channels and tubing. This could be quite 
readily be addressed in future microfluidic devices, though, by 
employing intelligent channel designs, having extra SiPMs 
present to allow background correction, or by surrounding the 
SiPMs in a small amount of shielding such that radioactivity is 
only detected in the region of interest. 
Conclusions 
We have investigated the use of low-cost, commercially 
available SiPMs for the detection of radioactivity within 
microfluidic channels, towards quality control testing of PET 
radiotracers. Microfluidic devices fabricated from common 
substrates were placed directly onto an array of SiPMs, 
whereupon it was found that the type of chip material had an 
almost negligible effect, while the thickness of the substrate 
had a profound influence. We also determined that, despite 
being light sensors, the bulk of the SiPM signal occurred due to 
direct interaction of the positrons and  rays emitted from the 
radioactive sources. Finally, we demonstrated the application 
of the SiPM array for the determination of the activity level 
and half-life of [
18
F]FDG, as well as detection of the PET
radiotracer, [
68
Ga]gallium-citrate, and the SPECT radiotracer,
[
99m
Tc]pertechnetate. The results provide the groundwork
from which more focused radioanalysis systems can be built 
for a wide range of PET and SPECT tracers, with the findings 
enabling optimisation of the design of a dedicated microfluidic 
quality control device. Further studies will involve 
characterisation of sources of the signal, noise and error that 
will in turn be used, in addition to other improvements, to 
optimise the setup for achieving more precise half-life 
measurements. Evaluation of the spatial resolution and 
acquisition times that can be achieved with such an optimised 
SiPM platform will lead to development of the setup towards 
microfluidic radio-TLC and radio-HPLC analyses, with particular 
interests being the ability to measure separated plugs of 
radioactivity in flow. 
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